Search results for "schizophrenia."

showing 10 items of 592 documents

Specific executive/attentional deficits in patients with schizophrenia or bipolar disorder who have a positive family history of psychosis

2003

Neurocognitive impairments are well documented in patients with schizophrenia and their healthy first-degree biological relatives. Less is known about neuropsychological performance in bipolar disorders, but some studies indicate that, compared to schizophrenia, bipolar disorder displays a similar profile pattern with less severe deficits. The genetic and environmental contributions to the development of neurocognitive deficits are also unclear. This study explored the effect of a family history (FH) of psychotic disorders in first-degree relatives on a variety of cognitive domains (abstraction and flexibility, verbal fluency, verbal memory, motor activity and visual-motor processing/attent…

AdultMalePsychosismedicine.medical_specialtyBipolar DisorderAdolescentNeuropsychological TestsSeverity of Illness Indexmental disordersmedicineHumansVerbal fluency testAttentionBipolar disorderFirst-degree relativesPsychiatryBiological PsychiatryAgedNeuropsychologyMiddle Agedmedicine.diseaseDiagnostic and Statistical Manual of Mental DisordersPsychiatry and Mental healthPsychotic DisordersSchizophreniaSchizophreniaFemaleVerbal memoryCognition DisordersPsychologyNeurocognitiveJournal of Psychiatric Research
researchProduct

Neurocognitive diagnosis and cut-off scores of the Screen for Cognitive Impairment in Psychiatry (SCIP-S)

2009

To demonstrate the ability of the Screen for Cognitive Impairment in Psychiatry (SCIP-S) to discriminate between cognitively-impaired individuals and those with adequate functioning in a sample of schizophrenic and bipolar patients, as well as in a control group.The SCIP-S, together with a full neuropsychological battery, was administered to three groups: patients with schizophrenia, patients diagnosed with bipolar disorder I, and controls. The battery scores were used to perform a standardization with respect to the control group and this served to determine the comparison groups (cognitively impaired versus unimpaired) for each of the subtests of the SCIP-S. A full analysis of decision va…

AdultMalePsychosismedicine.medical_specialtyBipolar DisorderNeuropsychological TestsSeverity of Illness Indexmental disordersmedicineHumansBipolar disorderPsychiatryBiological PsychiatryCognitive deficitPsychiatric Status Rating ScalesReceiver operating characteristicCognitive disorderCognitionMiddle Agedmedicine.diseasePsychiatry and Mental healthROC CurveSchizophreniaSchizophreniaFemalemedicine.symptomCognition DisordersPsychologyNeurocognitiveClinical psychologySchizophrenia Research
researchProduct

Relationship between insight, violence and diagnoses in psychotic patients

2010

Abstract Introduction Lack of insight is a common clinical problem in psychiatric patients, but few times has been properly studied until recently. Patients with good insight tend to show a better treatment adherence with a better prognosis and show less hostility. This study aims to investigate whether there is a relationship between the hostility degree and insight or not and to analyse if there are insight quantitative differences between the patients regarding their diagnoses. Method One hundred and sixty-eight psychotic patients were studied (including 86 patients with schizophrenia and 43 with bipolar disorder). PANNS P7 (hostility) item and G14 (poor impulse control) were analysed in…

AdultMalePsychosismedicine.medical_specialtyBipolar Disorderbusiness.industryPsychological interventionHuman factors and ergonomicsPoison controlHostilityGeneral MedicineAwarenessViolencemedicine.diseaseSchizophreniaInjury preventionHumansMedicineFemaleSchizophrenic PsychologyBipolar disordermedicine.symptombusinessPsychiatryRevista de Psiquiatría y Salud Mental (English Edition)
researchProduct

Seroquel (ICI 204 636), a putative "atypical" antipsychotic, in schizophrenia with positive symptomatology: results of an open clinical trial and cha…

1995

Preclinical data indicated that seroquel (ICI 204 636), a dibenzothiazepine with 5-HT2 and D2-like receptor antagonistic properties, might be an effective antipsychotic agent, causing fewer extrapyramidal side effects than typical neuroleptics. In the present study, 12 patients suffering from schizophrenia or schizophreniform disorder with predominantly positive symptomatology were treated in an open clinical trial for 4 weeks with seroquel at a maximum dosage of 750 mg/day. The drug was generally well tolerated, and virtually no adverse extrapyramidal side effects such as acute dystonia, parkinsonism or akathisia were observed. Total scores for BPRS (item score 0–6; baseline: 42.0±2.3; mea…

AdultMalePsychosismedicine.medical_specialtyDibenzothiazepinesTime Factorsmedicine.drug_classmedicine.medical_treatmentAtypical antipsychoticThyrotropinAkathisiaGastroenterologyQuetiapine FumarateAntipsychotic AgentInternal medicinemedicineHumansSchizophreniform disorderAntipsychoticAgedPharmacologyPsychiatric Status Rating ScalesParkinsonismElectroencephalographyMiddle Agedmedicine.diseaseProlactinTreatment OutcomeSchizophreniaAnesthesiaSchizophreniaFemaleSchizophrenic Psychologymedicine.symptomPsychologyAntipsychotic AgentsPsychopharmacology
researchProduct

The relevance of cognitive, clinical and premorbid variables in predicting functional outcome for individuals with first-episode psychosis: A 3 year …

2013

Real-world functional deficits are common and persistent in individuals with psychosis. Cognitive deficits have been shown to compromise functioning. We aimed to study the predictive values of premorbid, sociodemographic, and baseline clinical and neurocognitive factors on long-term functional outcome for individuals with first episode non-affective psychosis. We failed to demonstrate a significant relationship between cognitive deficits at baseline and functional disability at 3 year follow-up. Diagnosis of schizophrenia (OR=2.457, p=0.011), shorter education (OR=1.177, p=0.005) and poor premorbid social adjustment (OR=1.628, p=0.013) emerged as the strongest predictors for the 114 subject…

AdultMalePsychosismedicine.medical_specialtyLongitudinal studyAdolescentNeuropsychological TestsOutcome (game theory)Disability EvaluationYoung AdultPredictive Value of TestsmedicineHumansLongitudinal StudiesPsychiatryBiological PsychiatryRetrospective StudiesFirst episodeCognitionMiddle AgedPrognosismedicine.diseasePsychiatry and Mental healthLogistic ModelsPsychotic DisordersSocioeconomic FactorsSchizophreniaFemaleCognition DisordersPsychologyNeurocognitiveAntipsychotic AgentsDiagnosis of schizophreniaPsychiatry Research
researchProduct

Spectroscopic metabolomic abnormalities in the thalamus related to auditory hallucinations in patients with schizophrenia

2008

Abstract Objective Previous studies have found neurochemical abnormalities in thalamic nuclei in patients with schizophrenia. These abnormalities have been associated with information processing deficiencies and symptom formation. There are no metabolic spectroscopy studies in patients with schizophrenia attending to auditory hallucinations. The aim of the present study is to explore metabolic Magnetic Resonance Spectroscopy (MRS) ratio differences in the thalamus between schizophrenic patients with and without auditory hallucinations and control subjects. Methods MRS studies (MRI 1.5 T unit) were performed in 49 patients with schizophrenia (30 with auditory hallucinations and 19 without au…

AdultMalePsychosismedicine.medical_specialtyMagnetic Resonance SpectroscopyHallucinationsThalamusAudiologyFunctional LateralityCholineThalamusBrief Psychiatric Rating ScalemedicineBrief Psychiatric Rating ScaleHumansBiological PsychiatryAspartic AcidAuditory hallucinationmedicine.diagnostic_testPositive and Negative Syndrome ScaleMagnetic resonance imagingCreatinemedicine.diseaseDiagnostic and Statistical Manual of Mental DisordersPsychiatry and Mental healthSchizophreniaSchizophreniaAge of onsetmedicine.symptomPsychologyNeuroscienceSchizophrenia Research
researchProduct

Familial liability to schizophrenia and mood disorders and cognitive impairment in psychosis.

2015

Schizophrenia and other psychoses are complex disorders with high rates of cognitive impairment and a considerable degree of genetic and environmental influence on its etiology. Whether cognitive impairment is related to dimensional scores of familial liability is still matter of debate. We conducted a cross-sectional study including 169 patients with psychotic disorders and 26 healthy controls. Attention, memory and executive functions were assessed, and familial loading scores for schizophrenia and mood disorders were calculated. The relationships between familial liability and neuropsychological performance were examined with Spearman׳s correlation coefficients. In addition, patients wer…

AdultMalePsychosismedicine.medical_specialtyMatched-Pair Analysisbehavioral disciplines and activitiesSeverity of Illness IndexExecutive FunctionVisual memoryMemorymental disordersSeverity of illnessmedicineHumansAttentionBipolar disorderPsychiatryBiological PsychiatryMood DisordersNeuropsychologymedicine.diseaseExecutive functionsPsychiatry and Mental healthCross-Sectional StudiesMood disordersPsychotic DisordersSchizophreniaSchizophreniaFemalePsychologyCognition DisordersClinical psychologyPsychiatry research
researchProduct

Early age of onset, brain morphological changes and non-consistent motor asymmetry in schizophrenic patients.

1999

Previous data suggest abnormalities in the consistence of motor dominance in schizophrenia (e.g. mixed-handedness, poor correlation between hand, eye and foot preferences and an increase of hand-eye crossed dominance). The aim of this work is to examine the clinical significance of hand-eye and hand-foot crossed dominance in a sample of 61 right-handed schizophrenic patients. The application of multivariate analysis revealed that 23 right-handed and non-right-eyed patients (crossed hand-eye dominant group) had a significant earlier clinical onset and smaller brain size, global and frontal area, than 38 right-handed and right-eyed schizophrenics (consistent hand-eye dominance group). These f…

AdultMalePsychosismedicine.medical_specialtyMultivariate analysisgenetic structuresCentral nervous systemAudiologyNeuropsychological TestsFunctional LateralityDevelopmental psychologymedicineHumansClinical significanceBiological PsychiatryDominance (genetics)Retrospective StudiesAge FactorsBrainmedicine.diseaseeye diseasesPsychiatry and Mental healthmedicine.anatomical_structureMotor SkillsBrain sizeLateralitySchizophreniaFemalesense organsAge of onsetPsychomotor DisordersPsychologySchizophrenia research
researchProduct

Subchronic haloperidol downregulates dopamine synthesis capacity in the brain of schizophrenic patients in vivo

2003

Udgivelsesdato: 2003-Apr The antipsychotic effect of neuroleptics cannot be attributed entirely to acute blockade of postsynaptic D(2)-like dopamine (DA) receptors, but may arise in conjunction with the delayed depolarization block of the presynaptic neurons and reduced DA synthesis capacity. Whereas the phenomenon of depolarization block is well established in animals, it is unknown if a similar phenomenon occurs in humans treated with neuroleptics. We hypothesized that haloperidol treatment should result in decreased DA synthesis capacity. We used 6-[(18)F]fluoro-L-dopa (FDOPA) and positron emission tomography (PET) in conjunction with compartmental modeling to measure the relative activi…

AdultMalePsychosismedicine.medical_specialtyPatientsDopamineDown-RegulationStatistics NonparametricDopamineInternal medicinemedicineHaloperidolHumansPharmacologybusiness.industryPutamenDopamine antagonistBrainDepolarizationHuman brainMiddle Agedmedicine.diseasePsychiatry and Mental healthEndocrinologymedicine.anatomical_structureCerebral cortexAnesthesiaSchizophreniaHaloperidolbusinessTomography Emission-Computedmedicine.drug
researchProduct

Psychiatric and neurological symptoms in patients with Niemann-Pick disease type C (NP-C): Findings from the International NPC Registry

2017

Objectives: Niemann-Pick disease type C (NP-C) is a rare inherited neurovisceral disease that should be recognised by psychiatrists as a possible underlying cause of psychiatric abnormalities. This...

AdultMalePsychosismedicine.medical_specialtyPediatricsInternationalityAdolescentDiseaseYoung Adult03 medical and health sciences0302 clinical medicinehemic and lymphatic diseasesmedicinePsychiatric abnormalitiesHumansIn patientProspective StudiesRegistriesAge of OnsetChildPsychiatryBiological PsychiatryAgedNiemann–Pick disease type Cbusiness.industryMental Disordersnutritional and metabolic diseasesNiemann-Pick Disease Type CMiddle Agedmedicine.disease030227 psychiatryPsychiatry and Mental healthSchizophreniaChild PreschoolFemalebusinessThe World Journal of Biological Psychiatry
researchProduct